Intuitive Surgical, Inc. (ISRG)
USD 526.47
(-3.43%)
USD 526.47
(-3.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.39 Billion USD | 38.77% |
| 2022 | 1.57 Billion USD | -13.39% |
| 2021 | 1.82 Billion USD | 73.46% |
| 2020 | 1.04 Billion USD | -23.62% |
| 2019 | 1.37 Billion USD | 14.6% |
| 2018 | 1.32 Billion USD | 13.73% |
| 2017 | 1.15 Billion USD | 11.57% |
| 2016 | 1.05 Billion USD | 27.73% |
| 2015 | 740 Million USD | 35.83% |
| 2014 | 619.2 Million USD | -36.09% |
| 2013 | 919.8 Million USD | -2.92% |
| 2012 | 935.9 Million USD | 26.38% |
| 2011 | 741.3 Million USD | 25.14% |
| 2010 | 595.6 Million USD | 47.1% |
| 2009 | 377.43 Million USD | 12.36% |
| 2008 | 335.91 Million USD | 52.85% |
| 2007 | 219.76 Million USD | 54.09% |
| 2006 | 107.35 Million USD | 87.62% |
| 2005 | 75.49 Million USD | 170.97% |
| 2004 | 21.18 Million USD | 1805.35% |
| 2003 | -1.25 Million USD | 89.47% |
| 2002 | -15.67 Million USD | 0.55% |
| 2001 | -15.67 Million USD | 9.78% |
| 2000 | -17.52 Million USD | -0.64% |
| 1999 | -17.3 Million USD | 43.76% |
| 1998 | -30.77 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 693.5 Million USD | 2.12% |
| 2024 Q1 | 578.7 Million USD | 4.5% |
| 2024 Q2 | 679.1 Million USD | 17.35% |
| 2023 FY | - USD | 38.77% |
| 2023 Q3 | 574.4 Million USD | 24.01% |
| 2023 Q4 | 573.4 Million USD | -0.17% |
| 2023 Q2 | 463.2 Million USD | 19.5% |
| 2023 Q1 | 387.6 Million USD | 4.05% |
| 2022 Q4 | 372.5 Million USD | -6.62% |
| 2022 Q2 | 397.6 Million USD | -2.57% |
| 2022 Q1 | 408.1 Million USD | -9.39% |
| 2022 FY | - USD | -13.39% |
| 2022 Q3 | 398.9 Million USD | 0.33% |
| 2021 Q1 | 416.8 Million USD | 0.24% |
| 2021 Q2 | 511.2 Million USD | 22.65% |
| 2021 Q3 | 442.6 Million USD | -13.42% |
| 2021 Q4 | 450.4 Million USD | 1.76% |
| 2021 FY | - USD | 73.46% |
| 2020 Q3 | 270.4 Million USD | 235.48% |
| 2020 Q1 | 283 Million USD | -28.82% |
| 2020 Q2 | 80.6 Million USD | -71.52% |
| 2020 FY | - USD | -23.62% |
| 2020 Q4 | 415.8 Million USD | 53.77% |
| 2019 Q2 | 359 Million USD | 42.35% |
| 2019 FY | - USD | 14.6% |
| 2019 Q1 | 252.2 Million USD | -31.52% |
| 2019 Q4 | 397.6 Million USD | 8.72% |
| 2019 Q3 | 365.7 Million USD | 1.87% |
| 2018 Q3 | 313.3 Million USD | 2.19% |
| 2018 Q1 | 276.7 Million USD | -15.38% |
| 2018 Q2 | 306.6 Million USD | 10.81% |
| 2018 FY | - USD | 13.73% |
| 2018 Q4 | 368.3 Million USD | 17.56% |
| 2017 Q2 | 257.5 Million USD | 34.46% |
| 2017 FY | - USD | 11.57% |
| 2017 Q4 | 327 Million USD | 17.37% |
| 2017 Q3 | 278.6 Million USD | 8.19% |
| 2017 Q1 | 191.5 Million USD | -27.57% |
| 2016 Q2 | 245.4 Million USD | 21.25% |
| 2016 Q1 | 202.4 Million USD | -17.69% |
| 2016 Q4 | 264.4 Million USD | 3.12% |
| 2016 FY | - USD | 27.73% |
| 2016 Q3 | 256.4 Million USD | 4.48% |
| 2015 Q1 | 130.4 Million USD | -36.82% |
| 2015 Q4 | 245.9 Million USD | 29.49% |
| 2015 Q3 | 189.9 Million USD | 9.26% |
| 2015 FY | - USD | 35.83% |
| 2015 Q2 | 173.8 Million USD | 33.28% |
| 2014 Q3 | 159.1 Million USD | 11.26% |
| 2014 FY | - USD | -36.09% |
| 2014 Q1 | 56.6 Million USD | -72.87% |
| 2014 Q2 | 143 Million USD | 152.65% |
| 2014 Q4 | 206.4 Million USD | 29.73% |
| 2013 FY | - USD | -2.92% |
| 2013 Q3 | 174.2 Million USD | -20.27% |
| 2013 Q4 | 208.6 Million USD | 19.75% |
| 2013 Q2 | 218.5 Million USD | -13.02% |
| 2013 Q1 | 251.2 Million USD | 1.25% |
| 2012 Q3 | 211.4 Million USD | -6.17% |
| 2012 Q4 | 248.1 Million USD | 17.36% |
| 2012 FY | - USD | 26.38% |
| 2012 Q2 | 225.3 Million USD | 16.55% |
| 2012 Q1 | 193.3 Million USD | -8.82% |
| 2011 Q1 | 148.3 Million USD | -9.85% |
| 2011 FY | - USD | 25.14% |
| 2011 Q2 | 168.1 Million USD | 13.35% |
| 2011 Q3 | 178.9 Million USD | 6.42% |
| 2011 Q4 | 212 Million USD | 18.5% |
| 2010 FY | - USD | 47.1% |
| 2010 Q1 | 129.7 Million USD | -5.37% |
| 2010 Q3 | 132.1 Million USD | -5.44% |
| 2010 Q4 | 164.5 Million USD | 24.53% |
| 2010 Q2 | 139.7 Million USD | 7.71% |
| 2009 Q3 | 104.49 Million USD | 4.97% |
| 2009 Q1 | 53.02 Million USD | -41.24% |
| 2009 FY | - USD | 12.36% |
| 2009 Q2 | 99.54 Million USD | 87.73% |
| 2009 Q4 | 137.06 Million USD | 31.17% |
| 2008 Q2 | 84.36 Million USD | 21.38% |
| 2008 Q4 | 90.24 Million USD | -1.72% |
| 2008 Q3 | 91.81 Million USD | 8.84% |
| 2008 Q1 | 69.5 Million USD | -9.86% |
| 2008 FY | - USD | 52.85% |
| 2007 Q4 | 77.1 Million USD | 34.38% |
| 2007 Q1 | 37.19 Million USD | -41.66% |
| 2007 FY | - USD | 54.09% |
| 2007 Q2 | 48.1 Million USD | 29.34% |
| 2007 Q3 | 57.37 Million USD | 19.28% |
| 2006 Q3 | 28.27 Million USD | 5.93% |
| 2006 FY | - USD | 87.62% |
| 2006 Q1 | 23.9 Million USD | -17.38% |
| 2006 Q2 | 26.69 Million USD | 11.7% |
| 2006 Q4 | 63.74 Million USD | 125.43% |
| 2005 FY | - USD | 170.97% |
| 2005 Q1 | 9.85 Million USD | -31.45% |
| 2005 Q2 | 16.01 Million USD | 62.45% |
| 2005 Q3 | 21.21 Million USD | 32.5% |
| 2005 Q4 | 28.92 Million USD | 36.33% |
| 2004 Q4 | 14.38 Million USD | 120.74% |
| 2004 Q3 | 6.51 Million USD | 15.84% |
| 2004 FY | - USD | 1805.35% |
| 2004 Q2 | 5.62 Million USD | 266.86% |
| 2004 Q1 | 1.53 Million USD | 11.82% |
| 2003 Q4 | 266 Thousand USD | 176.55% |
| 2003 Q3 | -1.48 Million USD | -217.98% |
| 2003 FY | - USD | 89.47% |
| 2003 Q1 | -1.9 Million USD | -633.42% |
| 2003 Q2 | 1.86 Million USD | 155.34% |
| 2002 Q4 | -1.82 Million USD | 93.81% |
| 2002 FY | - USD | 0.55% |
| 2002 Q3 | -5.66 Million USD | -66.25% |
| 2002 Q2 | -3.1 Million USD | 34.89% |
| 2002 Q1 | -5.08 Million USD | -420.04% |
| 2001 Q1 | -4.02 Million USD | 17.92% |
| 2001 Q4 | -3.9 Million USD | 81.25% |
| 2001 FY | - USD | 9.78% |
| 2001 Q3 | -4.68 Million USD | -28.2% |
| 2001 Q2 | -3.76 Million USD | -10.88% |
| 2000 Q3 | -4.07 Million USD | -4.2% |
| 2000 Q1 | -4.63 Million USD | 0.0% |
| 2000 FY | - USD | -0.64% |
| 2000 Q4 | -4.9 Million USD | -20.43% |
| 2000 Q2 | -3.9 Million USD | 15.7% |
| 1999 FY | - USD | 43.76% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 5346.538% |
| AngioDynamics, Inc. | -14.29 Million USD | 16851.329% |
| AtriCure, Inc. | -8.1 Million USD | 29623.986% |
| Avinger, Inc. | -16.34 Million USD | 14746.397% |
| Azenta, Inc. | 55.15 Million USD | -4240.991% |
| BioLife Solutions, Inc. | -45.23 Million USD | 5392.232% |
| The Cooper Companies, Inc. | 882.8 Million USD | -171.194% |
| Daxor Corporation | 329.74 Thousand USD | -725956.893% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 18239.87% |
| Femasys Inc. | -13.16 Million USD | 18279.249% |
| GlucoTrack, Inc. | -7.09 Million USD | 33862.516% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -25119.636% |
| Hologic, Inc. | 1.29 Billion USD | -84.701% |
| ICU Medical, Inc. | 307.69 Million USD | -678.078% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 25570.263% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -4786.916% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 36511.42% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 36511.42% |
| Masimo Corporation | 236.7 Million USD | -911.449% |
| Microbot Medical Inc. | -10.63 Million USD | 22613.636% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -15080.828% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -934.428% |
| Nephros, Inc. | -1.37 Million USD | 173711.313% |
| NovoCure Limited | -175.86 Million USD | 1461.328% |
| NEXGEL, Inc. | -2.73 Million USD | 87795.971% |
| NEXGEL, Inc. | -2.73 Million USD | 87795.971% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 2867.874% |
| OraSure Technologies, Inc. | 76.15 Million USD | -3043.596% |
| Pro-Dex, Inc. | 8.33 Million USD | -28630.349% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 5750.86% |
| Predictive Oncology Inc. | -13.18 Million USD | 18261.871% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 95408.388% |
| QuidelOrtho Corporation | 545.6 Million USD | -338.801% |
| Repligen Corporation | 124.29 Million USD | -1826.19% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 828230.351% |
| STAAR Surgical Company | 33.22 Million USD | -7106.586% |
| Sharps Technology, Inc. | -8.98 Million USD | 26759.196% |
| Utah Medical Products, Inc. | 24.8 Million USD | -9551.683% |
| DENTSPLY SIRONA Inc. | 232 Million USD | -931.94% |
| Jin Medical International Ltd. | 3.44 Million USD | -69437.612% |